Gary J R Cook

9PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 31, 2026
Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung Cancer.

Robert O'Shea, Carolyn Horst, Thubeena Manickavasagar

|Apr 05, 2025
PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer.

Daniel Johnathan Hughes, Gitasha Chand, Jessica Johnson

|Feb 22, 2024
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.

Daniel Johnathan Hughes, Eleni Josephides, Robert O'Shea

|May 31, 2023
Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer.

Daniel Johnathan Hughes, Gitasha Chand, Jessica Johnson

|Dec 23, 2022
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study

Daniel Johnathan Hughes, Matthaios Kapiris, Andreja Podvez Nevajda

|Jun 28, 2022
18F FDG PET/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer.

Daniel J Hughes, Manil Subesinghe, Benjamin Taylor

Pageof 2

Frequent Collaborators

6 joint publications

Vicky Goh

6 joint publications

Gary J R Cook

3 joint publications

James Spicer

3 joint publications

Gitasha Chand